Tuesday - March 31, 2026

Urothelial Carcinoma Clinical Trial Pipeline Expands as 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market Entry, Finds DelveInsight | Janssen Research and Development, MedPacto

Urothelial Carcinoma – Pipeline Insight, 2026 DelveInsight’s “Urothelial Carcinoma – Pipeline Insight, 2026” report provides comprehensive insights about 40+ companies, such as Janssen Research and Development, MedPacto, AstraZeneca, QED Therapeutics, Inovio Pharmaceuticals, Abbisko Therapeutics, Bayer, 4D pharma, RemeGen, Infinity Pharmaceuticals, … Continue reading

Myotonic Dystrophy (DM) Clinical Trial Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | AMO Pharma, Lupin, Harmony Biosciences

Myotonic Dystrophy (DM) – Pipeline Insight, 2026 DelveInsight’s “Myotonic Dystrophy (DM) – Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies, including AMO Pharma, Lupin, Harmony Biosciences, Avidity Biosciences, Dyne Therapeutics, Vertex Pharmaceuticals, Arrowhead Pharmaceuticals, Inc., Pepgen Corporation, Aparito, … Continue reading

Ottawa Window Medics Offers Homeowners a Smarter Alternative to Costly Window Replacement

Industry-Leading Window Defogging, Glass Replacement, and Door Repair Services in Ottawa Help Homeowners Save Up to 70% Compared to Full Replacement Costs OTTAWA, Ontario – Ottawa Window Medics, the region’s trusted window and door restoration specialists, is helping Ottawa homeowners … Continue reading